Approval · Notice of Compliance 1606 · 1999
SERC: Notice of Compliance 1606
Issued August 6, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1606
- Date
- August 6, 1999
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for changes to the product monograph and labelling
- Therapeutic class
- Anti-vertigo agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SERC | Not yet assigned | — |
Medicinal ingredients
- BETAHISTINE HYDROCHLORIDE 4 MG per TAB